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Abstract
Background: Although the prevalence of substance use disorder (SUD) with co-occurring attention deficit/
hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) is relatively high in adult patients, there is hardly
any knowledge about these dual diagnoses. A recent study reported met- and unmet needs for several life domains
regarding these patient groups. To improve treatment, it is necessary to identify the everyday life consequences of
SUD and co-occurring ADHD or ASD in adult patients.
Methods: Qualitative study using in-depth interviews. 11 SUD + ADHD and 12 SUD + ASD patients participated in
the study. The interview transcripts were coded and analysed according to the seven steps for descriptive
phenomenology by Colaizzi.
Results: Both patients with ADHD and patients with ASD can get caught in a jumble of thoughts and emotions
which can often lead to agitation and impulsivity in the case of ADHD or passivity and melancholia in the case of
ASD with co-occurring SUD in both cases. Initially substance use ameliorates the symptoms and related problems,
but both patient groups can later experience even greater problems: difficulties with the structuring of daily life
due to a lack of planning (SUD + ADHD) or due to a lack of initiative (SUD + ASD). Both groups indicate that
structure helps them function better. They also recognize that substance use disorganizes their lives and that an
absence of structure contributes to substance use in what becomes a vicious circle which needs to be broken for
effective treatment and care.
Conclusions: This study provides insight into the daily life consequences of SUD with a co-occurring ADHD or
ASD. Substance use is reported to solve some ADHD- or ASD-related problems in the short run but have negative
consequences in the long run (i.e., contribute to already impaired cognitive functioning). Insight is provided into
what clinicians can do to break this vicious circle and thus help ADHD patients to refrain from action and ASD
patients to take action.
Keywords: Substance use disorders, Attention deficit hyperactivity disorder, Autism spectrum disorder, Everyday life
consequences, Adults
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Background
Mental disorders can frequently co-occur with a substance
use disorder (SUD) or some other disorder. Such co-
occurrence is often referred to as a dual diagnosis, which
can itself refer to either life-time co-occurrence or current
co-occurrence. For clinical purposes and needs assessment,
current co-occurrence is more important than life-time co-
occurrence.
The co-occurrence of SUD and other mental disorders is
very common: about 50% of individuals with severe and
persistent mental disorders are affected by substance use
[1-3]. Some studies have specifically examined the co-
occurrence of SUD with schizophrenia, bipolar disorder,
psychosis, depressive disorder or anxiety disorder [1,4,5].
Similarly, the co-occurrence of SUD with attention deficit/
hyperactivity disorder (ADHD) has been examined quite
extensively. And a recent meta-analysis of the prevalence of
attention-deficit hyperactivity disorder in substance use
disorder patients showed 23% of all patients with SUD to
meet the criteria for adult ADHD [6]. Studies of the co-
occurrence of SUD and autism spectrum disorders (ASD)
are scarce [7]. In recent research, however, the lifetime
prevalence of SUD in connection with ASD has been re-
ported to range from 11% to 29% [8-10]. The sample sizes
have been limited (n = 122, n = 54 and n = 70 respectively)
in these studies, however.
A very recent study showed about 1% of the general
population to have adult ADHD with a co-occurring
SUD while 0.1-0.2% of the general population has an
ASD with a co-occurring SUD [11].
Studies have further shown the co-occurrence of SUD
with other psychiatric disorders to be associated with not
only ineffective treatment and care but also an unfavour-
able treatment course and outcome [12-14]. In a recent
study the objective care needs of SUD patients with co-
occurring ADHD or ASD were determined [11]. Met- and
unmet needs were reported for several life domains and it
was suggested that further research should focus on the
(subjective) psychological consequences of substance use
in SUD patients with ADHD (SUD +ADHD) or ASD
(SUD +ASD). This calls for in-depth, qualitative study of
substance use and related daily problems.
In light of the above, we undertook a qualitative, interview
study to answer the following research question: What are
the everyday life consequences of substance use in adult pa-
tients with a substance use disorder (SUD) and co-occurring
attention deficit/hyperactivity disorder (ADHD) or autism
spectrum disorder (ASD) from a patient’s perspective?
Methods
Study design and procedure
A qualitative, interview study was conducted among a
population of treatment-seeking patients with a dual diag-
nosis of SUD and ADHD or SUD and ASD.
Open, in-depth semi-structured interviews were used in
which patients in both groups were questioned about the
consequences of their illness for everyday life using the pa-
tient’s perspective as the guiding principle. The study was
approved by a certified medical ethics committee (Commis-
sie Mensgebonden Onderzoek Regio Arnhem-Nijmegen)
and by the institutional review board of Dimence (Commis-
sie Wetenschappelijk Onderzoek). All participants signed
informed consent for participation in the study.
The interviews were conducted first with a group of
SUD +ADHD patients in the period of December 2011 to
May 2012 and then with a group of SUD+ASD patients
in the period of June 2012 to October 2012. All of the in-
terviews were conducted by one of two researchers who
thus conducted half of the interviews for each patient
group. The interviews were then transcribed verbatim.
Target patient population and selection criteria
Patients with SUD and a co-occurring ADHD or ASD
were recruited using the following inclusion and exclu-
sion criteria. Inclusion: outpatient treatment for SUD;
age 18–65; IQ >80; current DSM-IV diagnosis of SUD
and current DSM-IV diagnosis of ADHD or ASD; mas-
tery of the Dutch language. Exclusion: diagnoses of SUD
and both ADHD and ASD. All patients were recruited
from an outpatient, dual diagnosis, treatment facility in
the Netherlands.
Out of 122 patients, 72 told that they were willing to
participate in the further study. Of these 72 patients,
nine were diagnosed with both ADHD and ASD in
addition to SUD and therefore excluded from further in-
clusion, leaving a total of 63 eligible patients.
A total of 37 SUD + ADHD patients were then
approached for this study: seven patients could no longer
be reached and 13 refused to participate despite their ini-
tial willingness to do so. An interview was thus planned
for 17 patients, but 5 did not show up then. One patient
also had to be excluded due to hospitalization at the time
of the planned interview. This left 11 SUD+ADHD pa-
tients to participate in the study.
A total of 26 SUD +ASD patients were approached for
this study as well: 5 could no longer be reached and 7
refused to participate despite initial willingness to do so.
An interview was planned for 14 patients, but 2 of them
did not show up. In the end, 12 SUD + ASD patients
were interviewed for a total of 23 patients participating
in the present study.
Interview topics
The in-depth interviews were conducted with the aid of
a topic list which draws upon the results of a previous-
study [11]. Impairments, unmet needs, and clearly met
needs were probed for a number of life domains (see
Table 1).
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The topic list was used as guidance during the interview.
By posing open questions, the patients were invited to de-
scribe in detail their ideas, attitudes, experiences, and be-
haviour. Sample questions were: What are your problems
like, and how do they relate to your alcohol or drug use?
What does this combination of SUD and ADHD/ASD
mean for you? and How does the combination of SUD and
ADHD/ASD relate to your everyday life?
Coding and analysis of the interview transcripts
Given the qualitative nature of our study, the interview
transcripts were coded and analyzed in a cyclic process.
However, keeping the groups separated helped to focus
on the in-depth knowledge within each group. Through-
out this process, the routines followed and the coding
procedures applied were discussed between the re-
searchers and, in this manner, consistency of assessment
was assured. The coding and analysis of the data was
performed using the MAXQDA2010 software. And, in
doing this, the seven steps for descriptive phenomen-
ology outlined by Colaizzi [15] were followed.
In order to gain an overall impression of the data, the
interview transcripts were first read as a whole (step 1).
Then both interviewers independently selected and
coded significant statements (steps 2 and 3). Related
codes were then identified and grouped together under
the themes they represented (step 4). Thereafter, a sub-
set of 6 of the 23 interview transcripts was coded by
both researchers and the findings compared.
After the completion of the first 7 interviews for each
of the patient groups, an interim analysis was performed
(step 5). The results of this analysis were then used to
guide the subsequent interviews. The emerging themes
and insights were thoroughly discussed in preparation
for the subsequent interviews.
In the subsequent interviews, the themes identified in
step 5 were used to determine whether new codes would
emerge which could not be grouped within the existing
themes or data saturation was reached.
In the next step of the analyses, the interviews from
the two groups were examined as a whole but also com-
pared to identify general and group-specific themes (step
6). The outcomes of the analyses were then summarized
and sent to the participants for feedback and validation
of the results (written member check, step 7). Unfortu-
nately, none of the participants responded to our request
for a written member check.
Results
For both patient groups (SUD + ADHD N = 11; SUD +
ASD N = 12), the need for care according to the Euro-
pASI [11] was very similar to that of the total group of
eligible patients (N = 63) for 5 of the 8 EuropASI do-
mains. Only small differences were detected for the
other 3 domains. More SUD +ADHD patients in the
current sample were living alone and in both diagnostic
groups in the current sample more patients were
employed compared to the total eligible group. However,
the differences were small and we thus conclude that the
research groups were comparable to the total group of
eligible patients.
The interviews with the patients lasted 60 minutes on
average. The two patient groups were similar with regard
to most socio-demographic characteristics; they only dif-
fered on gender composition and primary substance use.
The SUD +ASD group included only males and 10 out
of the 12 patients reported alcohol as their primary sub-
stance of use. The SUD +ADHD group included three
women and eight men; primary substance use varied
(see Table 2).
Comparison of the initial steps in the coding and ana-
lysis of the interview transcripts showed that the re-
searchers had selected the same statements as significant,
assigned largely similar content codes to the selected
statements, and also grouped the coded statements into
similar themes.
Following the seven-step analytic procedure, the every-
day life consequences of a dual diagnosis of SUD and
ADHD or SUD and ASD were found to revolve around
three main themes: (1) jumbled thoughts and emotions,
(2) ambiguity of substance use, and (3) structure.
In the following, we further describe the everyday
consequences and supply illustrative quotations (with
the patient group and respondent number indicated in
parentheses).
Table 1 Interview topic list (i.e., domains of life for which
impairments and needs were probed)
Life domains indicated from previous
study
Topics for present
study
Psychiatric health
Psychological distress Mental health
Mental health
Drugs
Alcohol Addiction
Unemployment
Day time activity Daily activities
Looking after the home
Family/social relations
Company Social functioning
Money
Finances Finance
Physical health* Physical health
Sexuality** Sexuality
*SUD + ADHD only.
**SUD + ASD only.
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Jumble of thoughts and emotions
Both groups stated that they experience a jumble of
emotions, including anger, distress and anxiety. Partici-
pants also said that they did not recognize emotions very
well, and had difficulties understanding them. Further-
more, they were not able to handle their emotions and
found it hard to sort them out and to put them into per-
spective. They often failed to make the connection be-
tween event and feeling, and vice versa.
Distressed, sad, happy…. those things actually blend in
my case, so to name how I’m feeling, that’s hard to do.
(…) And that’s what sometimes happens to me, that I’m
really not feeling good and things just get worse because
I can’t figure out the reason why. (SUD +ASD 2)
The jumble of emotions experienced by both groups
of patients led to a vicious circle of negative thinking
and feeling which led to vicious circle of symptoms and
substance use. Both groups mentioned getting caught in
this vicious circle and not being able to get out of it by,
for instance, stopping the flow of negative thoughts and
emotions.
That’s because of us [people with ADHD] thinking that
fast and much, and often we [people with ADHD] fill in
many things by ourselves, and pick things up, a lot.
That’s why things come on stronger to us [people with
ADHD] and stick longer. (SUD +ADHD 11)
The patients in the SUD + ADHD group frequently
stated that they could not handle the flood of thoughts
and emotions which they experienced. This could lead
to agitation, which could trigger further impulsiveness.
What is meant here is that patients cannot put the break
on and therefore race past their own and others limits
with serious negative consequences, such as using more
addictive substances and/or experiencing more interper-
sonal conflicts.
In contrast, patients in the SUD + ASD group fre-
quently expressed that the overload of stimuli caused by
the jumble of thoughts and emotions made them passive
and melancholic. This obviously had a negative impact
on their quality of life. Feeling lonely and searching for
some perspective in life are frequently mentioned by pa-
tients with SUD +ASD. In a relationship or similar con-
tact, passive and melancholic feelings were also often
reported to stand in the way of sexual activity.
I always go on, and on, and on (…) you just get tired
and more tired. The consequence of this is becoming
less focused, and that makes you more and more
impulsive. (SUD +ADHD 11)
Especially when I’m tired and worn out, I become very
hyper (…) then you go bouncing. Becoming more inefficient.
(…) what I’ll often do then, when I’m totally worn out, is
use drugs… really lots of them.... (SUD+ADHD 7)
I’ve got the idea that I can get lost in my head, in
thought, which makes me lose time sometimes and that is
what’s keeping me from getting to action. (SUD +ASD 3)
By now I know my mind is processing data very slowly,
and if I want to live a pleasant and meaningful life then
I’ll have to stop working as hard as I did before and I
shouldn’t want to anymore. But that’s a hard nut to crack.
(…) and to me that’s still intense and it really makes me
worry about if I’ll get a girlfriend ever? Will I ever get to
live with someone? (…) And sometimes that really makes
me sad (…). It makes me feel lonely. (SUD+ASD 2)
I was longing for a relationship for a long time,
because that’s the standard. However, it being the
standard is not a very good reason to have a relation,
I guess. (…) I’ve been in bed with a girl sometimes, and
then I’m lying there and I just don’t know what to do,
how to act, what’s normal. (SUD + ASD 4)
Table 2 Demographic and clinical characteristics of two
dual-diagnosis patient groups (n = 23)
SUD + ADHD SUD + ASD
Total n 11 12
Male n (%) 8 (73%) 12 (100%)
Age (mean) 43 37
Living
Alone n (%) 6 (55%) 5 (42%)
With other(s ) n (%) 5 (45%) 7 (58%)
Employment
Employed n (%) 6 (55%) 6 (50%)
Substance of abuse (more than 3 years)
Alcohol n (%) 2 (18%) 3 (25%)
Cannabis n (%) - 1 (8%)
Alcohol + cocaine n (%) 3 (27%) -
Alcohol + cannabis n (%) 1 (9%) 5 (42%)
Alcohol + medication n (%) - 1 (8%)
Alcohol + cocaine + amphetamine + ecstasy
n (%)
2 (18%) -
Alcohol +medication + cocaine +
amphetamine + cannabis n (%)
1 (9%) -
Alcohol + heroine + cocaine +
amphetamine + ecstasy n (%)
1 (9%) -
Alcohol + cocaine + amphetamine +
cannabis + XTC n (%)
- 1 (8%)
Extreme variety of substances (>6) n (%) 2 (18%) 1 (8%)
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Ambiguity of substance use
Substance use was reported to serve a clear purpose for
both of the patient groups. It suppressed the jumble of
thoughts and emotions, the agitation, and the melancho-
lia. For the SUD +ADHD group, substance use served to
decrease the level of hyperactivity but was also often
boundless: one bottle of beer led to the drinking of an
entire case. For the SUD +ASD group, substance use
was reported to help suppress the jumble of thoughts
and emotions, to help them relax and get through the
day, and to help them escape feelings of pure boredom.
Giving myself a bit of peace, so it doesn’t get out of
control. That my brain stops thinking, particularly.
Stops going on, and on, and on. (SUD +ADHD 8)
Then we had children, and the stress got higher. (…) Well,
I started drinking, just to inhibit the stimuli, to subdue
them. (….) that helped me get through the evening. It was
just to survive, not for the booze. (SUD+ASD 3)
At the same time, the patients from both groups re-
ported substance use to worsen their symptoms and the
problems stemming from their ADHD or ASD.
Especially when I had a relapse or used again, then I
noticed becoming disordered for a long period. (…) and
that’s when you let impulses rule you. (SUD+ADHD 11)
It has the effect that I don’t function properly, and
that I hardly eat (…) Everything gets worse by using.
(SUD + ASD 10)
Stopping with substance use was reported to produce
clear benefits by most of the SUD +ADHD patients.
They experienced better physical and mental health as a
result of quitting. They nevertheless indicated that quit-
ting was a struggle because everything which their sub-
stance use had suppressed came to the surface … and
then more intensively. They further observed that bal-
anced use or controlled substance use in moderation
was something which they could not manage and there-
fore not an option.
I can’t restrain that, I just do it. I’ll blow, quaff or snort,
there’s no restraint whatsoever. I can’t go and drink one
beer, one beer becomes a case. (SUD +ADHD 6)
One of the SUD +ASD patients reported that it had
been relatively simple to stop and that he was not using
anymore, but the remainder of the SUD +ASD group re-
ported still using. These patients also reported searching
for a way to achieve a kind of balanced use — mostly
with professional guidance.
… I have decided that I won’t be quitting drinking fully,
because I noticed a great part of my social life will be
gone and to me that’s not worth it, and I don’t know
how it could be done without the booze. (SUD +ASD 2)
Structure
Both groups indicated that structure made them function
better in many areas of life: daily activities, social relation-
ships, finances, physical health, and sexuality. Having daily
activities, a job, and family further helped them structure
their lives and gave it meaning. Structure contributed to
break out of passivity and control impulsiveness.
But, if you get me sitting at home, then you’ve got
another alcoholic, that doesn’t work out. To me, that’s
my structure, my work and so forth. (SUD +ADHD 5)
A company for career counselling helps me to
reintegrate in work, and I told them I don’t want to
work in a big warehouse or with a boss or colleagues
that will rouse me, because that will go wrong. And I
don’t want to go back to my old lifestyle, that I’ll just
have to smoke a joint in the evening. (SUD +ASD 6)
I noticed that when I neglect the housekeeping I also
get more noise, more thoughts in my head (…) so I am
very occupied with getting more discipline in
housekeeping. (SUD +ASD 2)
Both groups further noted — as indicated in the pre-
ceding and following quotations — that substance use
disorganized their lives. In a vicious circle, lack of struc-
ture contributed to substance use and substance use
contributed to a further lack of structure.
When I don’t have a reason to get up in the morning (…)
then I tend to stay in bed and take it easy. I’ll smoke a
joint in the morning and will go back to sleep again. So,
I noticed, I need structure in my life. (SUD+ADHD 3)
I find it hard to fill my time — I don’t have many
hobbies — although structure is very important. It
happened that I got so bored that it made me think:
let’s drink tonight, so tomorrow I’ll sleep it off and then
another half day is filled. (SUD + ASD 5)
Patients in the SUD +ADHD group reported frequent
problems with the actual structuring of activities. They
mentioned knowing what they wanted to do, having the
necessary skills for social relationships or to make plans,
and believing that they could handle matters effectively.
But they found it hard to prioritize, keep focus on the
task at hand, and stay tuned into to not only their own
needs but also the needs of others. The result was major
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difficulties with maintaining structure, sustaining rela-
tionships, and managing finances.
I plan my time very inaccurately, and that takes a lot
of energy, takes a lot of effort. (…) Yes, that’s the result.
I get distracted by impulses, and I get distracted easily,
and that is what makes you spend time on the wrong
things. (SUD +ADHD 11)
I don’t know what to do if someone shares his emotions,
that makes me become very nervous. So I’ll walk away. I
had an affair with a woman for four years, and when
things went wrong I walked away. I don’t know how to
handle that. That’s not my cup of tea. (SUD +ADHD 5)
A lot of debts, once 3000 euros (…) because of my
impulsivity, of course. Not because of using weed, no,
I just bought all kinds of things. (SUD +ADHD 10)
The SUD +ASD patients also experienced problems
with structure but, in contrast to the SUD +ADHD
group: they hardly knew how to spend their spare time,
how to initiate a social relationship, and how to handle
other matters; such as their finances or household.
Things get into a routine, that’s what I don’t recognize.
(…) It may happen that I don’t get myself to work or
do other things for half a day (…) things seem to get
stuck in my head, like a needle in the groove of a
record, and I can’t get out of it. (SUD +ASD 11)
It doubles the handicap that you’ve got, makes it
really hard to take stock of situations. And the drugs
make you think even more … like … well … like
passive. You get even more passive. (SUD +ASD 6)
The thought of starting a social relationship or becoming
socially active is reported to make most of the patients in
the SUD+ASD group feel anxious and insecure. They re-
ported not being able to easily join in with others and use
substances to help them do this. Substance use suppressed
feelings of insecurity and overstimulation/oversensitivity,
made it easier for them to tune into people/situations, and
helped them focus and react during interactions.
But, when I have got to sit in sober, that really gives
me the jitters. (SUD +ASD 5)
… it [using alcohol] makes it easier to put things in
words, put it in words more quickly, react faster.
(SUD + ASD 3)
A number of the patients in the SUD +ASD group
also reported lacking sufficient insight in their finance,
because they did not take initiative and felt they were
not able to keep track of their finances.
I handed over financial and administrative matters to
an administrator, voluntarily. In the past, those were
daily activities that I didn’t get to. I noticed it, of
course, that pile of bills lying there. But no, I was too
scared to start on them. (SUD +ASD 4)
Overall, the interviews showed the patients getting
caught in a vicious circle of symptoms and substance
use in every life domain.
Discussion
With regard to the everyday life consequences of SUD
with co-occurring ADHD or ASD, it can be concluded
that the underlying mechanisms appear to differ for the
groups (i.e., impulsivity vs. passivity) but that the everyday
life consequences of having a dual disorder are similar: both
groups get caught in a vicious circle of symptoms and sub-
stance use. The cycle is more or less the same for the two
groups: a jumble of thoughts and emotions; increased
symptoms (i.e., impulsiveness or passivity); decreased
structure; increased substance use; and occurrence of even
more jumbled thoughts and emotions (see Figure 1). For
both groups of patients, the jumble of thoughts and emo-
tions can lead directly to agitation and substance use,
which initially ameliorates the symptoms but exacerbates
them later: for the SUD +ADHD group, substance use
typically leads to increased impulsiveness; for the SUD+
ASD group, substance use typically leads to increased pas-
sivity. In the long run, SUD increases the ADHD or ASD
symptoms and interferes with self-management.
Both groups function better when there is sufficient
structure. However, substance use destroys structure,
Figure 1 Vicious circle entailed by dual diagnosis of SUD with
ADHD or ASD.
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and this lack of structure can lead to a vicious circle of
increased substance use. The SUD + ADHD group of pa-
tients mainly lacks inhibition of impulsiveness and
therefore has considerable difficulties focusing as well as
maintaining structure. This created a situation of agita-
tion and thereby increased substance use and heightened
impulsivity, with a further loss of structure and in-
creased substance abuse as an outcome. In contrast, the
SUD +ASD group has problems with initiation, the
management of daily responsibilities, and getting into
and holding on to structure. The outcome is passivity
and melancholia, which can lead to substance use as a
form of coping (see Figure 1).
In their review, Kushner & Mueser [19] described four
models explaining the high prevalence of comorbid sub-
stance use disorders and other psychiatric disorders; the
common factor model, the secondary substance abuse
model, the secondary psychopathology model, and the
bidirectional model. The current study contains various
examples of processes consistent with each of these
models: impulsivity as a common vulnerability factor,
substance abuse to reduce dysphoria or to facilitate so-
cial engagement, substance abuse leading to impulsive
behavior or passivity, and - most of all - the presence of
(bidirectional) vicious circles of increasing substance
abuse and increasing psychopathology.
Dealing with impaired executive functioning
A possible key to treatment of SUD with a co-occurring
ADHD or ASD and thus breaking the vicious circle of
symptoms and substance use is attention to their cognitive
or so-called executive functioning (EF). The problems that
are solved by EF are essential for adequate social function-
ing. EF is essential for adequate functioning in two main
domains: inhibition and meta-cognition. Inhibition refers
to the ability of the individual to inhibit motor, verbal, cog-
nitive, and emotional activities. Meta-cognition refers to
the individual’s nonverbal working memory, verbal work-
ing memory, planning abilities, problem-solving abilities,
and emotional self-regulation [16].
For alcohol-dependent patients, research shows that
almost all executive functions are impaired [17-21]. For
the patients in our study and thus patients with a dual
diagnosis of ADHD or ASD and a co-occurring SUD, an
accumulation of EF impairments may thus be the case.
Barkley [16] recently found ADHD patients to have
both impaired inhibition and impaired meta-cognitive
functioning (i.e., both non-verbal and verbal working
memory limitations). Not being able to concentrate or
remember things for a longer period of time, patients
with ADHD may move from task to task without re-
engaging or finishing a task and thus leave a series of
uncompleted tasks behind them. This is consistent with
what we found in the present study for SUD +ADHD
patients who reported being impulsive, problems focus-
ing, trouble keeping focused, and difficulties maintaining
structure in several areas of their lives. SUD may thus
worsen the problems of patients with ADHD. This
means an accumulation of EF impairments.
ASD is also associated with impairments of both inhib-
ition and meta-cognition [22,23]. Patients with ASD have
been shown to have problems with intention formation
(i.e., performance planning), intention initiation (i.e., switch-
ing, time monitoring) and execution (i.e., task completion,
switching, planning adherence, efficiency). Flexibility re-
mains particularly impaired across ages in ASD, whereas
working memory, initiation, and organization become in-
creasingly problematic over time. SUD may thus worsen
the problems for patients. This means an accumulation
of EF impairments. This pattern of findings is consist-
ent with what we detected in the present study for the
SUD + ASD patients who reported being passive, diffi-
culties with structure, and problems organizing various
areas of their lives.
Clinical implications
The results of this qualitative, interview study show how
SUD creates a vicious circle of symptoms and substance
use in patients with a dual diagnosis of SUD and ADHD or
ASD. We also gained insight with this information into
what clinicians can do to break the vicious circle of symp-
toms and substance use: SUD+ADHD patients should be
helped to refrain from action and SUD+ASD patients
should be helped to take action. Patients should be helped
to create and maintain structure in their lives, and their
self-management skills need to be strengthened to do this.
In addition, SUD+ASD patients may initially be offered
controlled substance use in the absence of appropriate be-
havioural alternatives for the realization of a treatment goal.
A patient with SUD+ASD, for example, may be helped to
engage in social activities with reduced drinking (i.e., con-
trolled substance use) and thus to master the behavioural
repertoire needed to participate in social activities [24].
Clinicians should nevertheless realize that reduced sub-
stance use or total abstinence will not always result in bet-
ter planning, greater structure, or increased initiative. The
cognitive impairments arising from SUD add to the often
chronic, cognitive impairments associated with ADHD
and ASD, which means that reductions in substance use
may help but are not very likely to fully restore the cogni-
tive functioning of individual with a dual diagnosis of SUD
and ADHD or ASD. The goal of the treatment and care
for these patients should thus be maximization of their
long-term welfare — however the patient defines this —
by helping them to break the vicious circle of symptoms
and substance use. Support, reinforcement of available
skills, and viable alternatives for cognitive impairments
should always thus be considered.
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Strengths and limitations of the present study
The conduct of the interviews in the present study by
two independent researchers increases credibility and re-
liability [25]. Analysis of the data was performed by the
two researchers independently and final coding was
based on consensus between the two researchers. Data
saturation was reached when coding the statements se-
lected from the transcripts for discussion topic, main
themes, and relevant points, which indicates the validity
of the study [26].
The group of responders and non-responders were
comparable with regard to the intensity of care, which
suggests that our patient population was representative. A
limitation of the study was that the researchers did not
use cross-over blind coding, which would have added to
the reliability. Other possible limitations were that the
SUD +ASD group included only males and that co-
occurring mental health conditions aside from ADHD and
SUD or ASD and SUD were not assessed.
Conclusions
With regard to the everyday life consequences of SUD
with co-occurring ADHD or ASD, it can be concluded
that the underlying mechanisms appear to differ for the
groups (i.e., impulsivity vs. passivity) but that the every-
day life consequences of having a dual disorder are the
same: both groups get caught in a vicious circle of symp-
toms and substance use. Our findings show SUD co-
occurring with ADHD or ASD to be associated with EF
impairments and thus have consequences for the daily
life functioning and social interactions of patients. To
help patients cope with these cognitive deficits, their
treatment and care should be aimed at the areas of time
management, organization, problem solving, self-control,
motivation, and the regulation of emotions [27]. An inte-
grated cognitive behaviour therapy protocol [28] possibly
in combination with atomoxetine [29] or high doses of
methylphenidate [30] appears promising for the treat-
ment of SUD + ADHD. Further research is nevertheless
needed in these areas. To our knowledge, the treatment
of co-occurring SUD +ASD has not yet been studied.
Considering the negative consequences for the everyday
lives of the patients, the treatment possibilities for this
dual diagnosis group should be studied.
Further examination of the actual experiences of pa-
tients is needed to provide a clear basis for their treatment.
The treatment and care experiences of patients with
ADHD or ASD and a co-occurring SUD should be exam-
ined, for example, in order to gain insight into their opin-
ions about what contributes to their recovery and which
coping strategies should be reinforced and stimulated.
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